# Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

> **NCT00180947** · PHASE2 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 210 (—)

## Conditions studied

- Rhabdomyosarcomas
- Neoplasms, Connective and Soft Tissue
- Ewing Tumor
- Osteosarcomas
- Neuroblastomas
- Medulloblastomas

## Interventions

- **DRUG:** Vinorelbine, cyclofosfamide

## Key facts

- **NCT ID:** NCT00180947
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 210 (—)
- **Last updated:** 2006-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180947, "Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00180947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*